Marco Marotta
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Marco Marotta
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marco Marotta
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Malaria Consortium
 Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | Medical/Nursing Services | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree | |
Leiras
 Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| New Mexico State University | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Mumbai | College/University | Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree | |
| University of Helsinki | College/University | Doctorate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DMS IMAGING | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | ||
| Harvard Mit Health Sciences & Technology | College/University | Graduate Degree | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin | |
| Aalto University School of Business | College/University | Masters Business Admin | |
NovoCure GmbH
 NovoCure GmbH Pharmaceuticals: MajorHealth Technology Part of NovoCure Ltd., NovoCure GmbH is a German company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The company is based in Munich, Germany. The CEOs of the company are Asaf Danziger, Wilhelmus C. M. Groenhuysen. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SAVARA INC. | Pharmaceuticals: Major | President | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| Bristol-Myers Squibb Ilaçlari, Inc. | Chief Executive Officer | ||
| Bristol-Myers Squibb OOO | Chief Executive Officer | ||
| Organon Central East GmbH (Hanoi City Representative Office) | Corporate Officer/Principal | ||
| Dellmed Consulting | Founder | ||
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 15 |
| Frankreich | 6 |
| Schweiz | 5 |
| Finnland | 5 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 14 |
| Health Services | 2 |
| Process Industries | 2 |
Operativ
| Corporate Officer/Principal | 20 |
| Chief Executive Officer | 6 |
| Chief Operating Officer | 4 |
| Doctorate Degree | 4 |
| Masters Business Admin | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Marco Marotta
- Unternehmensverbindungen
